Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria

Infection and Immunity

Volumn 82, Issue 3, 2014, Pages 1343-1353

  Settles, Erik W ^a   Moser, Lindsey A ^a   Harris, Tajie H ^b   Knoll, Laura J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CHO CELLS; CRICETULUS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; MALARIA, CEREBRAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PARASITEMIA; PLASMODIUM BERGHEI; RECEPTORS, INTERLEUKIN-11; T-LYMPHOCYTES; TOXOPLASMA; TOXOPLASMOSIS; UP-REGULATION;

EID: 84894235779     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01259-13     Document Type: Article

References (87)

1. Anonymous. 2000. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl 1):S1-S90.
2. Medana IM, Turner GDH. 2006. Human cerebral malaria and the bloodbrain barrier. Int. J. Parasitol. 36:555-568. http://dx.doi.org/10.1016/j .ijpara.2006.02.004.
3. Silamut K, Phu NH, Whitty C, Turner GD, Louwrier K, Mai NT, Simpson JA, Hien TT, White NJ. 1999. A quantitative analysis of the microvascular sequestration of malaria parasites in thehumanbrain.Am.J. Pathol. 155:395-410. http://dx.doi.org/10.1016/S0002-9440(10)65136-X.
4. Clark IA, Awburn MM, Whitten RO, Harper CG, Liomba NG, Molyneux ME, Taylor TE. 2003. Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children. Malar. J. 2:6. http://dx.doi.org/10.1186/1475-2875-2-6.
5. Grau GE, Mackenzie CD, Carr RA, Redard M, Pizzolato G, Allasia C, Cataldo C, Taylor TE, Molyneux ME. 2003. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J. Infect. Dis. 187: 461-466. http://dx.doi.org/10.1086/367960.
6. Krishna S. 2012. Adjunctive management of malaria. Curr. Opin. Infect. Dis. 25:484-488. http://dx.doi.org/10.1097/QCO.0b013e3283567b20.
7. John CC, Kutamba E, Mugarura K, Opoka RO. 2010. Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev. Anti Infect. Ther. 8:997-1008. http://dx.doi.org /10.1586/eri.10.90.
8. Kihara M, Carter JA, Newton CRJC. 2006. The effect of Plasmodium falciparum on cognition: a systematic review. Trop. Med. Int. Health 11: 386-397. http://dx.doi.org/10.1111/j.1365-3156.2006.01579.x.
9. Idro R, Ndiritu M, Ogutu B, Mithwani S, Maitland K, Berkley J, Crawley J, Fegan G, Bauni E, Peshu N, Marsh K, Neville B, Newton C.2007. Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. JAMA 297:2232-2240. http://dx .doi.org/10.1001/jama.297.20.2232.
10. Rénia L, Potter SM, Mauduit M, Rosa DS, Kayibanda M, Deschemin J-C, Snounou G, Grüner AC. 2006. Pathogenic T cells in cerebral malaria. Int. J. Parasitol. 36:547-554. http://dx.doi.org/10.1016/j.ijpara.2006.02.007.
11. de Souza JB, Hafalla JCR, Riley EM, Couper KN. 2010. Cerebral malaria: why experimental murine models are required to understand the patho-genesis of disease. Parasitology 137:755-772. http://dx.doi.org/10.1017 /S0031182009991715.
12. Hunt NH, Grau GE, Engwerda C, Barnum SR, van der Heyde H, Hansen DS, Schofield L, Golenser J. 2010. Murine cerebral malaria: the whole story. Trends Parasitol. 26:272-274. http://dx.doi.org/10.1016/j.pt .2010.03.006.
13. Fauconnier M, Palomo J, Bourigault M-L, Meme S, Szeremeta F, Beloeil JC, Danneels A, Charron S, Rihet P, Ryffel B, Quesniaux VFJ.2012. IL-12Rβ2 is essential for the development of experimental cerebral malaria. J. Immunol. 188:1905-1914. http://dx.doi.org/10.4049/jimmu nol.1101978.
14. Amani V, Vigário AM, Belnoue E, Marussig M, Fonseca L, Mazier D, Rénia L. 2000. Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 30:1646-1655. http://dx.doi.org/10.1002 /1521-4141(200006)30:61646::AID-IMMU16463.0.CO;2-0.
15. Hermsen C, van de Wiel T, Mommers E, Sauerwein R, Eling W. 1997. Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology 114(Part 1):7-12. http://dx.doi.org/10.1017/S0031182096008293.
16. Sun G, Chang W-L, Li J, Berney SM, Kimpel D, van der Heyde HC.2003. Inhibition of platelet adherence to brain microvasculature protects against severe Plasmodium berghei malaria. Infect. Immun. 71:6553-6561. http://dx.doi.org/10.1128/IAI.71.11.6553-6561.2003.
17. Grau GE, Heremans H, Piguet PF, Pointaire P, Lambert PH, Billiau A, Vassalli P. 1989. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl. Acad. Sci. U. S. A. 86:5572-5574. http://dx.doi.org/10.1073/pnas.86.14.5572.
18. Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, Mazier D, Combadiere B. 2003. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 170:2221-2228.
19. Hansen DS, Bernard NJ, Nie CQ, Schofield L. 2007. NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium bergheimediated cerebral malaria. J. Immunol. 178:5779-5788.
20. Belnoue E, Kayibanda M, Vigário AM, Deschemin J-C, van Rooijen N, Viguier M, Snounou G, Rénia L. 2002. On the pathogenic role of brainsequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 169:6369-6375.
21. Engwerda CR, Mynott TL, Sawhney S, de Souza JB, Bickle QD, Kaye PM. 2002. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J. Exp. Med. 195:1371-1377. http://dx.doi.org/10.1084/jem.20020128.
22. Martins YC, Zanini GM, Frangos JA, Carvalho LJM. 2012. Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA. PLoS One 7:e32048. http://dx.doi .org/10.1371/journal.pone.0032048.
23. Penet M-F, Abou-Hamdan M, Coltel N, Cornille E, Grau GE, de Reggi M, Gharib B. 2008. Protection against cerebral malaria by the lowmolecular-weight thiol pantethine. Proc. Natl. Acad. Sci. U. S. A. 105: 1321-1326. http://dx.doi.org/10.1073/pnas.0706867105.
24. Reis PA, Comim CM, Hermani F, Silva B, Barichello T, Portella AC, Gomes FCA, Sab IM, Frutuoso VS, Oliveira MF, Bozza PT, Bozza FA, Dal-Pizzol F, Zimmerman GA, Quevedo J, Castro-Faria-Neto HC.2010. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog. 6:e1000963. http://dx.doi.org/10.1371/journal.ppat.1000 963.
25. Serghides L, Kim H, Lu Z, Kain DC, Miller C, Francis RC, Liles WC, Zapol WM, Kain KC. 2011. Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria. PLoS One 6:e27714. http://dx.doi.org /10.1371/journal.pone.0027714.
26. Morrell CN, Srivastava K, Swaim A, Lee MT, Chen J, Nagineni C, Hooks JJ, Detrick B. 2011. Beta interferon suppresses the development of experimental cerebral malaria. Infect. Immun. 79:1750-1758. http://dx .doi.org/10.1128/IAI.00810-10.
27. Franklin BS, Ishizaka ST, Lamphier M, Gusovsky F, Hansen H, Rose J, Zheng W, Ataíde MA, de Oliveira RB, Golenbock DT, Gazzinelli RT.2011. Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. Proc. Natl. Acad. Sci. U. S. A. 108:3689-3694. http://dx.doi.org/10.1073/pnas.1015406108.
28. Niikura M, Kamiya S, Nakane A, Kita K, Kobayashi F. 2010. IL-10 plays a crucial role for the protection of experimental cerebral malaria by coinfection with non-lethal malaria parasites. Int. J. Parasitol. 40:101-108. http://dx.doi.org/10.1016/j.ijpara.2009.08.009.
29. Voza T, Vigário AM, Belnoue E, Grüner AC, Deschemin J-C, Kayibanda M, Delmas F, Janse CJ, Franke-Fayard B, Waters AP, Landau I, Snounou G, Rénia L. 2005. Species-specific inhibition of cerebral malaria in mice coinfected with Plasmodium spp. Infect. Immun. 73:4777-4786. http://dx.doi.org/10.1128/IAI.73.8.4777-4786.2005.
30. Hochman S, Kim K. 2012. The impact of HIV coinfection on cerebral malaria pathogenesis. J. Neuroparasitol. 3:235547.
31. Amante FH, Haque A, Stanley AC, Rivera FDL, Randall LM, Wilson YA, Yeo G, Pieper C, Crabb BS, de Koning-Ward TF, Lundie RJ, Good MF, Pinzon-Charry A, Pearson MS, Duke MG, McManus DP, Loukas A, Hill GR, Engwerda CR. 2010. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J. Immunol. 185:3632-3642. http://dx.doi.org/10.4049/jimmunol.1000944.
32. Bucher K, Dietz K, Lackner P, Pasche B, Fendel R, Mordmüller B, Ben-Smith A, Hoffmann WH. 2011. Schistosoma co-infection protects against brain pathology but does not prevent severe disease and death in a murine model of cerebral malaria. Int. J. Parasitol. 41:21-31. http://dx.doi .org/10.1016/j.ijpara.2010.06.008.
33. Specht S, Ruiz DF, Dubben B, Deininger S, Hoerauf A. 2010. Filariainduced IL-10 suppresses murine cerebral malaria. Microbes Infect. 12: 635-642. http://dx.doi.org/10.1016/j.micinf.2010.04.006.
34. Eckwalanga M, Marussig M, Tavares MD, Bouanga JC, Hulier E, Pavlovitch JH, Minoprio P, Portnoï D, Rénia L, Mazier D. 1994. Murine AIDS protects mice against experimental cerebral malaria: downregulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Proc. Natl. Acad. Sci. U. S. A. 91:8097-8101. http://dx.doi.org /10.1073/pnas.91.17.8097.
35. Dubey JP. 1998. Advances in the life cycle of Toxoplasma gondii. Int. J. Parasitol. 28:1019-1024. http://dx.doi.org/10.1016/S0020-7519(98)000 23-X.
36. Dubey JP, Jones JL. 2008. Toxoplasma gondii infection in humans and animals in the United States. Int. J. Parasitol. 38:1257-1278. http://dx.doi .org/10.1016/j.ijpara.2008.03.007.
37. Pollard AM, Knoll LJ, Mordue DG. 2009. The role of specific Toxoplasma gondii molecules in manipulation of innate immunity. Trends Parasitol. 25:491-494. http://dx.doi.org/10.1016/j.pt.2009.07.009.
38. Yarovinsky F, Sher A. 2006. Toll-like receptor recognition of Toxoplasma gondii. Int. J. Parasitol. 36:255-259. http://dx.doi.org/10.1016/j.ijpara .2005.12.003.
39. Mason NJ, Liou H-C, Hunter CA. 2004. T cell-intrinsic expression of c-Rel regulates Th1 cell responses essential for resistance to Toxoplasma gondii. J. Immunol. 172:3704-3711.
40. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, Sher A. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308:1626-1629. http://dx.doi.org/10.1126/science.1109893.
41. Aliberti J, Valenzuela JG, Carruthers VB, Hieny S, Andersen J, Charest H, Reis e Sousa C, Fairlamb A, Ribeiro JM, Sher A. 2003. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat. Immunol. 4:485-490. http://dx.doi.org/10.1038/ni915.
42. Alexander J, Hunter CA. 1998. Immunoregulation during toxoplasmosis. Chem. Immunol. 70:81-102. http://dx.doi.org/10.1159/000058701.
43. Denkers EY, Gazzinelli RT. 1998. Regulation and function of T-cellmediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11:569-588.
44. Yap GS, Sher A. 1999. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201:240-247. http://dx.doi.org/10.1016/S0171-2985(99)80064-3.
45. Neyer LE, Grunig G, Fort M, Remington JS, Rennick D, Hunter CA.1997. Role of interleukin-10 in regulation of T-cell-dependent and T-cellindependent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65:1675-1682.
46. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, Liesenfeld O, Fort M, Kang H, Gufwoli E. 2000. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 164:5375-5382.
47. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA. 2005. A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J. Neuroimmunol. 165:63-74. http://dx.doi.org/10.1016/j.jneuroim.2005 .04.018.
48. O'Brien KB, Schultz-Cherry S, Knoll LJ. 2011. Parasite-mediated upregulation of NK cell-derived gamma interferon protects against severe highly pathogenic H5N1 influenza virus infection. J. Virol. 85:8680-8688. http://dx.doi.org/10.1128/JVI.05142-11.
49. Ruskin J, Remington JS. 1968. Immunity and intracellular infection: resistance to bacteria in mice infected with a protozoan. Science 160:72-74. http://dx.doi.org/10.1126/science.160.3823.72.
50. Mahmoud AA, Warren KS, Strickland GT. 1976. Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii. Nature 263:56-57. http://dx.doi.org/10.1038/263056a0.
51. Gentry LO, Remington JS. 1971. Resistance against Cryptococcus conferred by intracellular bacteria and protozoa. J. Infect. Dis. 123:22-31. http://dx.doi.org/10.1093/infdis/123.1.22.
52. Remington JS, Merigan TC. 1969. Resistance to virus challenge in mice infected with protozoa or bacteria. Proc. Soc. Exp. Biol. Med. 131:1184-1188. http://dx.doi.org/10.3181/00379727-131-34066.
53. Charest H, Sedegah M, Yap GS, Gazzinelli RT, Caspar P, Hoffman SL, Sher A. 2000. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria. J. Immunol. 165:2084-2092.
54. Mengs U, Pelster B. 1982. The course of Plasmodium berghei infection in mice latently infected with Toxoplasma gondii. Cell. Mol. Life Sci. 38: 570-571. http://dx.doi.org/10.1007/BF02327054.
55. Omata Y, Yagami K, Takei Y, Suzuki N, Nakabayashi T. 1981. Protective reaction against malaria infection in mice sensitized with frozenthawed toxoplasma tachyzoites. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 250:223-235.
56. Suzuki N, Kikushima K, Miyagami T, Igarashi I, Sakurai H, Saito A, Osaki H. 1987. Modulator effect of Toxoplasma lysate antigen in mice experimentally infected with Plasmodium berghei. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 264:422-434.
57. Denkers EY, Gazzinelli RT, Hieny S, Caspar P, Sher A. 1993. Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specific cytolytic T lymphocytes. J. Immunol. 150:517-526.
58. Mordue DG, Scott-Weathers CF, Tobin CM, Knoll LJ. 2007. A patatinlike protein protects Toxoplasma gondii from degradation in activated macrophages. Mol. Microbiol. 63:482-496. http://dx.doi.org/10.1111/j .1365-2958.2006.05538.x.
59. Amani V, Boubou MI, Pied S, Marussig M, Walliker D, Mazier D, Renia L. 1998. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infect. Immun. 66:4093-4099.
60. Carroll RW, Wainwright MS, Kim K-Y, Kidambi T, Gómez ND, Taylor T, Haldar K. 2010. A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria. PLoS One 5:e13124. http: //dx.doi.org/10.1371/journal.pone.0013124.
61. Hed J, Dahlgren C, Rundquist I. 1983. A simple fluorescence technique to stain the plasma membrane of human neutrophils. Histochemistry 79: 105-110. http://dx.doi.org/10.1007/BF00494347.
62. Hermsen CC, Telgt DS, Linders EH, van de Locht LA, Eling WM, Mensink EJ, Sauerwein RW. 2001. Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol. Biochem. Parasitol. 118: 247-251. http://dx.doi.org/10.1016/S0166-6851(01)00379-6.
63. Rooney PJ, Ayong L, Tobin CM, Moreno SNJ, Knoll LJ. 2011. TgVTC2 is involved in polyphosphate accumulation in Toxoplasma gondii. Mol. Biochem. Parasitol. 176:121-126. http://dx.doi.org/10.1016/j.molbiopara .2010.12.012.
64. Payne TM, Payne AJ, Knoll LJ. 2011. A Toxoplasma gondii mutant highlights the importance of translational regulation in the apicoplast during animal infection. Mol. Microbiol. 82:1204-1216. http://dx.doi.org /10.1111/j.1365-2958.2011.07879.x.
65. Baptista FG, Pamplona A, Pena AC, Mota MM, Pied S, Vigário AM.2010. Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect. Immun. 78:4033-4039. http://dx.doi.org/10.1128/IAI.00079-10.
66. Thumwood CM, Hunt NH, Clark IA, Cowden WB. 1988. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 96:579-589. http://dx.doi.org/10.1017/S0031182000080203.
67. Medana IM, Chaudhri G, Chan-Ling T, Hunt NH. 2001. Central nervous system in cerebral malaria: "innocent bystander" or active participant in the induction of immunopathology? Immunol. Cell Biol. 79:101-120. http://dx.doi.org/10.1046/j.1440-1711.2001.00995.x.
68. Hawkins BT, Egleton RD. 2006. Fluorescence imaging of blood-brain barrier disruption. J. Neurosci. Methods 151:262-267. http://dx.doi.org /10.1016/j.jneumeth.2005.08.006.
69. Grau GE, Piguet PF, Engers HD, Louis JA, Vassalli P, Lambert PH.1986. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J. Immunol. 137:2348-2354.
70. Claser C, Malleret B, Gun SY, Wong AYW, Chang ZW, Teo P, See PCE, Howland SW, Ginhoux F, Rénia L. 2011. CD8+ T Cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS One 6:e18720. http://dx.doi.org/10.1371/journal.pone.0018720.
71. Belnoue E, Potter SM, Rosa DS, Mauduit M, Grüner AC, Kayibanda M, Mitchell AJ, Hunt NH, Rénia L. 2008. Control of pathogenic CD8+ Tcell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 30:544-553. http://dx.doi.org/10.1111/j.1365-3024.2008.01053.x.
72. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237:1210-1212. http://dx.doi.org/10.1126/science .3306918.
73. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A. 1994. Parasite-induced IL-12 stimulates early IFNgamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.
74. Reis e Sousa C, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN, Sher A. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:1819-1829. http: //dx.doi.org/10.1084/jem.186.11.1819.
75. El-Assaad F, Wheway J, Mitchell AJ, Lou J, Hunt NH, Combes V, Grau GE. 2013. Cytoadherence of Plasmodium berghei-infected red blood cells to murine brain and lung microvascular endothelial cells in vitro. Infect. Immun. 81:3984-3991. http://dx.doi.org/10.1128/IAI.00428-13.
76. Kossodo S, Monso C, Juillard P, Velu T, Goldman M, Grau GE. 1997. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 91:536-540. http://dx.doi.org/10.1046/j.1365-2567.1997 .00290.x.
77. Haque A, Best SE, Unosson K, Amante FH, de Labastida F, Anstey NM, Karupiah G, Smyth MJ, Heath WR, Engwerda CR. 2011. Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J. Immunol. 186:6148-6156. http://dx.doi.org/10 .4049/jimmunol.1003955.
78. Nie CQ, Bernard NJ, Norman MU, Amante FH, Lundie RJ, Crabb BS, Heath WR, Engwerda CR, Hickey MJ, Schofield L, Hansen DS. 2009. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog. 5:e1000369. http: //dx.doi.org/10.1371/journal.ppat.1000369.
79. Van den Steen PE, Deroost K, van Aelst I, Geurts N, Martens E, Struyf S, Nie CQ, Hansen DS, Matthys P, van Damme J, Opdenakker G. 2008. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines. Eur. J. Immunol. 38:1082-1095. http://dx.doi.org/10.1002/eji .200737906.
80. Perona-Wright G, Mohrs K, Szaba FM, Kummer LW, Madan R, Karp CL, Johnson LL, Smiley ST, Mohrs M. 2009. Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell Host Microbe 6:503-512. http://dx.doi.org/10.1016/j.chom .2009.11.003.
81. Normaznah Y, Halim AA, Outhayphone M, Zamri MR. 1999. Protective immunity against Plasmodium berghei malaria after administration of interleukin-12. Malays. J. Pathol. 21:123-125.
82. Sedegah M, Finkelman F, Hoffman SL. 1994. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. U. S. A. 91:10700-10702. http://dx.doi.org/10.1073/pnas.91.22 .10700.
83. Stevenson MM, Tam MF, Wolf SF, Sher A. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFNgamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155:2545-2556.
84. Reis e Sousa C, Yap G, Schulz O, Rogers N, Schito M, Aliberti J, Hieny S, Sher A. 1999. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 11: 637-647. http://dx.doi.org/10.1016/S1074-7613(00)80138-7.
85. Aliberti J, Reis e Sousa C, Schito M, Hieny S, Wells T, Huffnagle GB, Sher A. 2000. CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells. Nat. Immunol. 1:83-87. http://dx .doi.org/10.1038/76957.
86. Aliberti J, Hieny S, Reis e Sousa C, Serhan CN, Sher A. 2002. Lipoxinmediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 3:76-82. http://dx.doi.org /10.1038/ni745.
87. Aliberti J, Valenzuela JG, Carruthers VB, Hieny S, Andersen J, Charest H, Reis e Sousa C, Fairlamb A, Ribeiro JM, Sher A. 2003. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat. Immunol. 4:485-490. http://dx.doi.org /10.1038/ni915.